Market Cap 219.79B
Revenue (ttm) 54.07B
Net Income (ttm) 7.04B
EPS (ttm) N/A
PE Ratio 16.29
Forward PE 15.66
Profit Margin 13.01%
Debt to Equity Ratio 0.73
Volume 8,034,200
Avg Vol 5,779,606
Day's Range N/A - N/A
Shares Out 3.10B
Stochastic %K 92%
Beta 0.40
Analysts Strong Sell
Price Target $86.07

Latest News on AZN

Why AstraZeneca May Be 2025's Most Underrated Pharma Stock

May 25, 2025, 4:50 AM EDT - 7 days ago

Why AstraZeneca May Be 2025's Most Underrated Pharma Stock


35 Barron's Pro-Picks: One Ideal May DiviDog

May 18, 2025, 4:51 AM EDT - 14 days ago

35 Barron's Pro-Picks: One Ideal May DiviDog

AGNC ASIX BDX CRM EPD FLMI FOX


Pharma firms maastraz

Apr 29, 2025, 12:06 PM EDT - 4 weeks ago

Pharma firms maastraz

GSK NVO NVS


AstraZeneca CEO talks tariffs, first quarter earnings

Apr 29, 2025, 11:35 AM EDT - 4 weeks ago

AstraZeneca CEO talks tariffs, first quarter earnings


AstraZeneca says may face further import tax fine from China

Apr 29, 2025, 2:10 AM EDT - 4 weeks ago

AstraZeneca says may face further import tax fine from China


AstraZeneca's Q1 2025 Financial Results

Apr 29, 2025, 2:00 AM EDT - 4 weeks ago

AstraZeneca's Q1 2025 Financial Results


Selling America, Buying Europe - My Picks

Apr 20, 2025, 9:15 AM EDT - 6 weeks ago

Selling America, Buying Europe - My Picks

ASML NVO